The Global Burden of Disease AMR project will be collecting data from all over the world to create a map of disease and deaths caused by drug-resistant infections, according to a news release from UK-based Wellcome, which announced that it will be investing £2.4 million ($3.2 million US) in the project as part of its efforts to address the AMR threat. The UK government and the Bill and Melinda Gates Foundation are providing additional funding.
The work will be carried out by researchers from the University of Oxford's Big Data Institute and Centre for Tropical Medicine and Global Health, in collaboration with researchers from the University of Washington's Institute for Health Metrics and Evaluation.
Over the next 4 years, the researchers will collect data on select bacteria-antibacterial drug combinations, generating global estimates of resistance for these "bug-drug" duos from 1900 to the present in 195 countries. They will produce detailed maps to help policymakers and researchers develop tailored future studies and interventions.
The data will be included in the Global Burden of Disease database, a tool that enables researchers to quantify health loss from diseases, injuries, and risk factors. Interactive data visualizations will be free and publicly accessible.
"The Global Burden of Disease AMR project will provide vital information on the spread and impact of drug-resistance—both critical to effectively targeting global efforts," Tim Jinks, PhD, Wellcome's head of drug resistance, said in the news release.
For further details, please see the source article here.